Large-scale testing (Phase 3)Ended earlyNCT02245568
What this trial is testing
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Who this might be right for
Alzheimer's DiseaseBehavioral Variant Frontotemporal Dementia
TauRx Therapeutics Ltd 913